Related Experiment Video
Updated: Jul 31, 2025

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease
Insights
Base editing efficiently converts CAG to CAA repeats, a strategy that shows promise for treating Huntington's disease (HD) by reducing harmful repeat expansions.
Area of Science:
- Genetics
- Molecular Biology
- Neurodegenerative Diseases
Background:
- Huntington's disease (HD) is caused by expanded CAG repeats in the huntingtin gene (HTT).
- The length of uninterrupted CAG repeats, not the polyglutamine tract, influences the age of HD onset.
- Targeting CAG repeat interruptions is a potential therapeutic strategy for HD.
Conclusions:
- Base editing is a feasible and specific method for converting CAG to CAA repeats.
- CAG-to-CAA conversion effectively reduces somatic repeat expansion, a key driver of Huntington's disease.
- This base editing approach holds therapeutic potential for Huntington's disease and other repeat expansion disorders.
Abstract:
An expanded CAG repeat in the huntingtin gene ( HTT ) causes Huntington's disease (HD). Since the length of uninterrupted CAG repeat, not polyglutamine, determines the age-at-onset in HD, base editing strategies to convert CAG to CAA are anticipated to delay onset by shortening the uninterrupted CAG repeat. Here, we developed base editing strategies to convert CAG in the repeat to CAA and determined their molecular outcomes and effects on relevant disease phenotypes. Base editing strategies employing combinations of cytosine base editors and gRNAs efficiently converted CAG to CAA at various sites in the CAG repeat without generating significant indels, off-target edits, or transcriptome alterations, demonstrating their feasibility and specificity. Candidate BE strategies converted CAG to CAA on both expanded and non-expanded CAG repeats without altering HTT mRNA and protein levels. In addition, somatic CAG repeat expansion, which is the major disease driver in HD, was significantly decreased by a candidate BE strategy treatment in HD knock-in mice carrying canonical CAG repeats. Notably, CAG repeat expansion was abolished entirely in HD knock-in mice carrying CAA-interrupted repeats, supporting the therapeutic potential of CAG-to-CAA conversion base editing strategies in HD and potentially other repeat expansion disorders.
Related Concept Videos
RNA Editing
Mutations
CRISPR
Genome Copying Errors
Point and Frameshift Mutations
DNA Base Pairing

